Execurve vs Propriotec: Research Comparison
Both products remain useful to compare from a technology and pricing-research perspective. However, they do not currently have the same Prop Firm Vendors introduction status: Propriotec remains in the active eligible set, while Execurve / PropScale is research-only pending re-verification.
Execurve vs Propriotec at a glance
| Area | Execurve / PropScale | Propriotec |
|---|---|---|
| PFV introduction status | Research only — re-verification required | Currently eligible for matcher consideration |
| Commercial model | Flat monthly pricing by trader count; provider states no revenue share | Flat monthly; provider states no setup, per-account or revenue-share fee |
| Public entry price | From €740/month for up to 500 traders | Not publicly disclosed |
| Trading platforms | MT4/MT5, cTrader, TradeLocker, IntraQuote; others on request | MT4/MT5, cTrader, Match-Trader, TradeLocker, HYPTRADER |
| CRM / lifecycle | Yes | Yes |
| Developer API | REST, WebSockets, webhooks advertised | Confirm exact API scope during demo |
Pricing research
Execurve gives buyers a useful public anchor: €740 per month for up to 500 traders. Propriotec states there are no setup fees, no per-account fees and no revenue share, but the monthly subscription must be obtained in a quote. These provider-stated economics remain useful for scenario modelling even while Execurve's introduction status is on hold.
Do not compare €740 directly with an unknown Propriotec quote without normalizing scope. Ask vendors to price the same platform integrations, trader/account volume, KYC, payment setup, migration, support and custom work for 12 months.
Platform and operating-stack research
Execurve publicly lists MetaTrader 4/5, cTrader, TradeLocker and its proprietary IntraQuote WebTrader, with additional platforms on request. Propriotec publicly lists MT4, MT5, cTrader, Match-Trader, TradeLocker and HYPTRADER. Both position their products as broader prop-firm operating stacks rather than generic CRMs.
Why verification status is separate from product research
A product can have useful public documentation without meeting our current threshold for a qualified introduction. Prop Firm Vendors separates product research from operational verification so historical or useful pricing data does not silently become an endorsement. Execurve can return to normal consideration if the re-verification requirements are cleared.
Questions for due diligence
- What is the complete 12-month cost at expected account/trader volume?
- Which trading-platform fees are included versus billed separately?
- What data can be exported on termination?
- Who owns custom integrations and workflows?
- What SLA and incident response are contractual?
- For Execurve specifically, what is the current contracting legal entity and official functioning business contact route?
Current buying path
If you want Prop Firm Vendors to help with introductions today, use Get Matched for the providers that currently clear our operational-integrity screen. Execurve remains available here as research but is not an active introduction option.
Methodology
Product facts use public provider information reviewed in September 2026. Verification status was updated 3 September 2026 after contact-route diligence. Provider claims are not independently audited unless explicitly stated. Commercial partnerships never determine editorial scoring.